Intestinal Bacteria Flora Disturbance Clinical Trial
Official title:
Prevalence Study Evaluating the Acquisition of Carriage of Resistant Bacteria in the Gut Flora in Volunteers From French Armed Forces Coming Back From External Operations
Prevalence Study evaluating the acquisition of carriage of multidrug-resistant Gram-negative bacteria (MDRGNB) in the gut flora in volunteers of French Armed Forces staying from 4 to 6 months outside France.
Emergence of MDRGN bacteria is blowing worldwide up leading to therapeutical failure in hospitalized patients with severe infections, as well as in outpatients with community-acquired infections such as UTI. Variation in prevalence exists across countries and regions. Travels outside own country of residence, like France, whatever the duration (short or long)or the reason (professional or leisure), are known risk factors for acquiring and disseminating MDRGN bacteria. Digestive carriage of multidrug-resistant Enterobacteriaceae could be a source of infection for the host as well as a source of dissemination. Qualitative and quantitative gut colonization by MDRGNB is poorly studied in non-hospitalized people who stayed for a few months out of France. The total amount of multidrug-resistant Enterobacteriaceae influences the spread of the dissemination. In our knowledge, no clinical study has been carried out to qualify and quantify gut colonization by MDRGNB in volunteers after staying 4-6 months outside country of residence such as France. A specific microbiological method will be evaluated in this study. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02538211 -
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
|
N/A | |
Completed |
NCT02220439 -
Does the Fecal Microbiome Influence Rotarix Immunogenicity
|
N/A | |
Completed |
NCT02539836 -
Study on Dietary Nutrition Intervention Techniques for Children Obesity
|
N/A | |
Recruiting |
NCT05461508 -
Fucoidan Assisted Eradication of Helicobacter Pylori
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667404 -
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
|
Phase 2 | |
Completed |
NCT02318134 -
Fecal Microbiota Transplantation for Pancreatitis
|
Phase 2 | |
Recruiting |
NCT04672889 -
Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis
|
N/A | |
Completed |
NCT03770143 -
Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
|
||
Completed |
NCT03103958 -
Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients
|
N/A | |
Not yet recruiting |
NCT05658055 -
The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication
|
Phase 4 | |
Recruiting |
NCT03018613 -
Fecal Microbiota Transplantation for Chronic Functional Constipation
|
Phase 1/Phase 2 | |
Recruiting |
NCT03016780 -
Fecal Microbiota Transplantation for Ulcerative Colitis
|
Phase 1/Phase 2 | |
Recruiting |
NCT03015467 -
Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)
|
Phase 1/Phase 2 | |
Completed |
NCT05016999 -
Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers.
|
N/A | |
Completed |
NCT02377063 -
The Effect of Fruit/Vegetable Drinks on the Human Intestine
|
N/A |